Fig. 1
Study design. MLD, metachromatic leukodystrophy; MPS II, mucopolysaccharidosis type II; MPS IIIA, mucopolysaccharidosis type IIIA
Fig. 1 | Journal of Patient-Reported Outcomes
Study design. MLD, metachromatic leukodystrophy; MPS II, mucopolysaccharidosis type II; MPS IIIA, mucopolysaccharidosis type IIIA